• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

[Researcher Comment] Fluoroquinolones significantly increase risk of serious arrhythmias

bys25qthea
December 5, 2012
in Cardiology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

Study author, Dr. Samy Suissa, PhD, talks to 2 Minute Medicine: Centre for Clinical Epidemiology, Jewish General Hospital, Montreal Quebec.

“Before our study, no study evaluated whether different fluoroquinolones carry different risks of cardiac rhythm disorders. Our large population-based study of over 600,000 patients found that the risk of serious arrhythmia is elevated with the use of all fluoroquinolones and that the risk is somewhat higher when a new treatment is started. This risk increase was particularly high with gatifloxacin”

 

 

 

Key study points:

RELATED REPORTS

Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States

1.  Fluoroquinolone use was associated with significantly increased risk of ventricular arrhythmias and death.

2.  The risk of arrhythmia varied between drugs and was greatest with gatifloxacin.

Primer: Fluoroquinolones are a class of antibiotics popular for their broad spectrum of activity and high oral bioavailability.  They are commonly used in both the outpatient and inpatient settings for respiratory, intra-abdominal and urinary tract infections.  Prior clinical trials and drug surveys have suggested the quinolone use is associated with a prolongation of the QTc interval and arrhythmias including torsades de pointes.  The phenomenon of quinolone-associated QT prolongation has been attributed to disruption of potassium channels that regulate the action potential of cardiac myocytes.  This study is the first population-based study assessing the risk of arrhythmia from quinolones that accounts for multiple confounders and examines each individual drug within the class.

Background reading:

1. Clinical use of the fluoroquinolones.

2. Cardiovascular and metabolic safety profiles of the fluoroquinolones.

3. Antimicrobial Safety: Focus on Fluoroquinolones.

This [nested case control] study: drew from medical record databases of all 7 million residents of Quebec.  Cases of ‘serious arrhythmia’ (defined as ventricular arrhythmia or sudden death) were selected from a cohort of 605,127 patients who had received a prescription for respiratory drugs and had no history of arrhythmias.  Up to 20 controls were selected for each case from the same cohort.  Adjusting for confounders and risk factors associated with arrhythmias, the authors calculated rate ratios (RR) using the incidence of serious arrhythmias within each group.  Analysis revealed that all quinolones were associated with a significantly increased risk of serious arrhythmia.  Gatifloxacin showed the highest increased risk with RR of 7.31 (95% CI 2.35 – 23.70).

In sum: This study reinforces prior evidence suggesting an association between quinolone use and serious arrhythmia and also identifies variations of this effect between the different drugs.  The limitations of this study include the inability to clinically validate the diagnosis of the arrhythmia, and the fact that case control studies are always subject to bias and confounding.  Given the increased use of quinolones, the results from this study might provide guidance in drug selection for a patient with significant risk factors for arrhythmias.

Click to read the study in CID

By [AS] and [MS]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

 

Previous Post

Local inhibition of enzyme improves endothelial vasodilatory response in heart disease patients with diabetes

Next Post

Anti-IL-1β antibody, Canakinumab, lowers plasma inflammatory biomarkers independently of plasma lipids and is well-tolerated in diabetics

RelatedReports

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force

June 24, 2022
RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Infectious Disease

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

June 24, 2022
Cardiovascular events in Kawasaki Disease not significantly elevated over controls
Chronic Disease

Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States

June 24, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Gastroenterology Classics

CT evaluation in pancreatitis strongly correlates with patient outcomes [Classics Series]

June 24, 2022
Next Post

Anti-IL-1β antibody, Canakinumab, lowers plasma inflammatory biomarkers independently of plasma lipids and is well-tolerated in diabetics

Protease inhibitor-based antiretroviral therapy in HIV-infected children decreases malaria in Sub-Saharan Africa

PET imaging findings may precede cognitive impairment in patients at high risk for Alzheimer’s disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.